Funding
Series D · Biotech

Drug Farm raises $55M Series D

Drug Farm raised $55 million in Series D financing announced in July.

Updated Oct 16, 2026By RoundOS Funding desk

Shanghai Pudong Leading Area Investment Center, Shanghai Puxing Collaborative Private Equity Fund, Tukar Capital, Fuzhou Xinhe Fund, Shenzhen Luohu Donghai Chempartner Investment Fund, Keyuan Pharma, BioVeda China Fund, YD Capital, Jiashan State VC, Detong Capital, Wedo Capital and Biometas are among its backers.

The company develops treatments for ROSAH syndrome, cardiovascular and kidney diseases, hepatitis B and metabolic disease.

Funding history

Series D · This round$55M

Sources

  1. Drug Farmprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related